Nuvectis Pharma, Inc.
NASDAQ:NVCT
8.35 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||
| Current Assets: | ||||||||||||||||
| Cash & Cash Equivalents
| 18.533 | 17.169 | 18.116 | 19.464 | 19.126 | 22.059 | 24.6 | 15.468 | 19.993 | 23.64 | 13.572 | 16.693 | 5.742 | 6.809 | 7.214 | 0 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 18.533 | 17.169 | 18.116 | 19.464 | 19.126 | 22.059 | 24.6 | 15.468 | 19.993 | 23.64 | 13.572 | 16.693 | 5.742 | 6.809 | 7.214 | 0 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 0.074 | 0.138 | 0.182 | 0.25 | 0.059 | 0.203 | 0.341 | 0.74 | 0.412 | 1.226 | 0.666 | 0.925 | 0.091 | 0 | 0 | 0 |
| Total Current Assets
| 18.607 | 17.307 | 18.298 | 19.714 | 19.185 | 22.262 | 24.941 | 16.208 | 20.405 | 24.866 | 14.238 | 17.618 | 5.833 | 6.809 | 7.214 | 0 |
| Non-Current Assets: | ||||||||||||||||
| Property, Plant & Equipment, Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.824 | 0 | 0 | 0 |
| Total Non-Current Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.824 | 0 | 0 | 0 |
| Total Assets
| 18.607 | 17.307 | 18.298 | 19.714 | 19.185 | 22.262 | 24.941 | 16.208 | 20.405 | 24.866 | 14.238 | 17.618 | 6.657 | 6.809 | 7.214 | 0 |
| Liabilities & Equity: | ||||||||||||||||
| Current Liabilities: | ||||||||||||||||
| Account Payables
| 2.498 | 2.261 | 1.846 | 1.759 | 2.771 | 3.492 | 1.803 | 2.096 | 2.91 | 2.251 | 1.434 | 1.349 | 1.058 | 0.495 | 0.389 | 0.033 |
| Short Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 6.396 | 4.055 | 3.924 | 3.933 | 4.213 | 2.084 | 2.806 | 1.838 | 3.276 | 2.241 | 1.304 | 1.71 | 1.361 | 0 | 0 | 0 |
| Total Current Liabilities
| 8.894 | 6.316 | 5.77 | 5.692 | 6.984 | 5.576 | 4.609 | 3.934 | 6.186 | 4.492 | 2.738 | 3.059 | 2.419 | 0.495 | 0.389 | 0.033 |
| Non-Current Liabilities: | ||||||||||||||||
| Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15.246 | 11.225 | 0 |
| Total Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.096 | 2.91 | 0 | 1.434 | 1.349 | 15.246 | 15.246 | 11.225 | 0 |
| Total Liabilities
| 8.894 | 6.316 | 5.77 | 5.692 | 6.984 | 5.576 | 4.609 | 3.934 | 6.186 | 4.492 | 2.738 | 3.059 | 17.665 | 15.741 | 11.614 | 0.033 |
| Equity: | ||||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14.238 | 17.618 | 15.246 | 15.246 | 11.225 | 0 |
| Common Stock
| 0 | 0 | 18,652.688 | 0 | 17,768.824 | 17,326.594 | 17,231.337 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings
| -73.245 | -66.997 | -62.844 | -58.416 | -54.245 | -47.623 | -41.742 | -36.034 | -31.985 | -25.289 | -19.412 | -15.843 | -12.9 | -10.639 | -5.971 | -0.033 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | -0 | 0 | 0 |
| Other Total Stockholders Equity
| 82.958 | 77.988 | 75.372 | 72.438 | 66.446 | 64.309 | 62.074 | 48.308 | 46.204 | 45.663 | 30.912 | 30.402 | 1.892 | -13.539 | -9.654 | 0 |
| Total Shareholders Equity
| 9.713 | 10.991 | 12.528 | 14.022 | 12.201 | 16.686 | 20.332 | 12.274 | 14.219 | 20.374 | 11.5 | 14.559 | -11.008 | -8.932 | -4.4 | -0.033 |
| Total Equity
| 9.713 | 10.991 | 12.528 | 14.022 | 12.201 | 16.686 | 20.332 | 12.274 | 14.219 | 20.374 | 11.5 | 14.559 | -11.008 | -8.932 | -4.4 | -0.033 |
| Total Liabilities & Shareholders Equity
| 18.607 | 17.307 | 18.298 | 19.714 | 19.185 | 22.262 | 24.941 | 16.208 | 20.405 | 24.866 | 14.238 | 17.618 | 6.657 | 6.809 | 7.214 | 0 |